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I. Zusammenfassung 
 
Schmerz ist eine lebenserhaltende biologische Funktion des Organismus, die den 
Körper sowohl vor potentiell gefährdenden, als auch vor bereits bestehenden 
Gewebeschäden warnt. Schmerz wird über die Aktivierung von 
Schmerzrezeptoren, sogenannten Nozizeptoren ausgelöst. Nozizeptoren sind 
spezialisierte Nervenendigungen, die auf starke mechanische, chemische und 
physikalische Reize reagieren. Die nozizeptive Information wird dann über 
schwach myelinisierte Aδ- und nicht myelinisierte C-Fasern in das Hinterhorn 
des Rückenmarks und in weiterer Folge in das Gehirn weitergeleitet, wo der 
Schmerz erstmals wahrgenommen wird. In den oberflächlichen Laminae I/II des 
Rückenmarks kann es an der ersten synaptischen Umschaltstelle zwischen 
afferenten Neuronen und verschiedenen nachgeschalteten Rückenmarksneuronen 
zur Modulation der nozizeptiven Information kommen. Unter pathologischen 
Bedingungen, wie peripheren Nervläsionen oder Entzündungen kann die 
nozizeptive Information moduliert werden. Hier kommt es zu einer veränderten 
Übertragung der nozizeptiven Information, die einer Verstärkung der 
Schmerzempfindlichkeit (Hyperalgesie) zugrunde liegen kann. Ein zelluläres 
Modell der Hyperalgesie ist die Langzeitpotenzierung (LTP) zwischen primär 
afferenten C-Fasern und nachgeschalteten Rückenmarksneuronen. Im 
Rückenmark nimmt sie eine Rolle als spinaler Schmerzverstärker ein, da es auf 
zellulärer Ebene zur längerfristigen Verstärkung der synaptischen Übertragung 
kommt. Im Zentrum der Beobachtungen standen zunächst lange Zeit neuronale 
Prozesse. Die Beteiligung nicht neuronaler Zellen an der synaptischen Plastizität 
wurde erst kürzlich untersucht. Neue Ergebnisse der letzten Jahre sprechen aber 
für die Bedeutung des am häufigst vorkommenden Zelltyps im zentralen 
Nervensystem: Gliazellen. Die Frage, die sich nun stellte, war, ob Gliazellen 
einen wesentlichen Einfluss auf die veränderte synaptische Übertragung bei einer 
spinalen LTP nehmen. 
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Transversalschnitte mit intakten dorsalen Wurzeln juveniler Ratten wurden 
angefertigt. Die dorsalen Wurzeln wurden mit einer Suction-Elektrode stimuliert 
und Ganzzellableitungen in Lamina I Neuronen des dorsalen Horns durchgeführt. 
Im Rahmen der Ganzzellableitungen wurden erregende postsynaptische Ströme 
(EPSCs) gemessen. Es wurde gezeigt, dass  Gliazellen und das von Gliazellen 
sekretierte Zytokin IL-1ß die synaptische Übertragungsstärke beeinflussen 
können. Gliazellen scheinen, den aufkommenden Daten zufolge, eine wichtige 
Rolle in der synaptischen Plastizität zu spielen. 
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II.  Abstract 
 
Pain is described as an unpleasant sensory and emotional experience which 
protects the body from damaging or potentially damaging situations, by activation 
of nociceptors. Nociceptors react in response to noxious mechanical, chemical, 
and physical stimuli. The nociceptive information is then transmitted from 
primary afferent Aδ- or C-fibers to the spinal dorsal horn. Already at the first 
synapse, between nociceptors and spinal dorsal horn neurons, nociceptive 
information can be modulated.  
Under pathological conditions like peripheral nerve injury and inflammation, 
nociceptive information can be modulated, and may be associated with an 
increased pain perception (hyperalgesia). A cellular model of hyperalgesia is 
long-term potentiation (LTP) between primary afferents and nociceptive- 
projection neurons in spinal dorsal horn. Neuronal plasticity was long thought to 
be entirely controlled by neurons.  
Over the last years, glia have emerged as important contributors to pathological 
and chronic pain conditions. Question arises, whether glia cells crucially 
influence synaptic plasticity in pain pathways.  
Transversal spinal cord slices with dorsal roots attached were dissected from rats. 
Dorsal roots were stimulated and excitatory postsynaptic currents (EPSCs) were 
recorded in spinal dorsal horn neurons. We showed that glia cells responded to a 
conditioning stimulus which also induced potentiation of EPSC- amplitudes in 
spinal dorsal horn neurons. We further demonsrated that the cytokine IL-1ß, 
secreted by glia cells, can increase synaptic strength. These findings suggest 
involvement of IL-1ß in induction and maintenance of synaptic plasticity between 
primary afferents and spinal dorsal horn neurons. Taken together, glia cells seem 
to be potential modulators of nociceptive transmission, and therefore key 
contributors to the development of pathological and chronic pain.  
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1. Introduction 
 
In the nociceptive system pain is induced upon activation of nociceptors. These 
are sensory nerve endings of primary afferent Aδ- or C-fibers that react to 
potentially damaging stimuli. These fibers contact spinal neurons some of which 
transmit the nociceptive information to the brain. Aδ-fibers are thinly myelinated 
axons which have moderate conduction velocities. Aδ-fibers are associated with 
acute, sharp pain. C-fibers are unmeylinated and have the smallest diameters and 
conduction velocities of all primary afferent fibers. They contribute to the second 
phase of pain perception, mediating long lasting, burning pain. The synapse 
between primary afferent Aδ- or C-fibers and spinal laminae I/II neurons is the 
first synapse where nociceptive information can be modified (Fig. 1).  
                                                
 
Figure 1: The nociceptive system: Primary afferent fibers convey nociceptive information 
from periphery to spinal dorsal horn neurons (mostly laminae I/II neurons) which further 
project to supraspinal centres. At the first synaptic connection in laminae I/II, between primary 
afferent fibers and laminae I/II neurons, nociceptive information can be modulated for the first 
time.  
 
Spinal mechanisms leading to the modulation of the nociceptive information 
include e.g. potentiation of synaptic strength, reduced synaptic inhibition or 
changes in intrinsic properties (Sandkühler, 2009;Woolf and Salter, 2000). 
Enhanced neuronal responsiveness can lead to facilitation of spinal nociception 
and further to an increased pain perception (hyperalgesia), following peripheral 
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nerve injury (Bennett and Xie, 1988) or inflammation (Lee et al., 2004). A 
proposed cellular model for hyperalgesia is the long-term potentiation (LTP) 
between primary afferent nociceptive fibers and spinal lamina I dorsal horn 
neurons (Ikeda et al., 2003; Ikeda et al., 2006). LTP is the enhanced state of 
neurotransmission, which arises after a conditioning stimulus, such as high 
frequency stimulation (HFS) of primary afferent fibres. Upon strong stimulation 
high amounts of the neurotransmitter glutamate are released. Glutamate then 
binds to the α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor 
(AMPAR), an ionotropic receptor for glutamate which mediates fast synaptic 
transmission. Following activation of AMPA receptors, Na
+
 flows into the 
postsynaptic neuron, resulting in a depolarization. Enhancement of synaptic 
transmission can be triggered by activation of the voltage-dependent, 
glutamatergic N-methyl D-aspartate receptor (NMDAR). NMDARs are 
ionotropic glutamate receptors which are also voltage-dependent, as a result of an 
ion channel block by extracellular Mg
2+
-ions. The activation of NMDA receptors 
causes, next to Na
+
, an influx of Ca
2+
. The rise in intracellular Ca
2+ 
([Ca
2+
]i)
 
triggers a cascade
 
of cellular signalling events which are necessary for the 
induction and sustained expression of LTP ( Ikeda et al., 2003; Ikeda et al., 2006). 
It has been shown, that the magnitude of [Ca
2+
]i is correlated with the magnitude 
of LTP in vitro (Ikeda et al., 2003). Recent studies showed that NMDAR opening 
may also be enhanced by NK1 receptor activation (Lieberman and Mody, 1998). 
At least two different stages of LTP can be distinguished depending upon its 
duration and signal transduction pathways involved. Early phase LTP is 
independent of novel protein synthesis and lasts from half an hour to 3 hours. 
Early phase LTP mainly includes phosphorylation of receptors/ion channels, or 
regulatory proteins, or cell-surface expression of channels in primary afferents 
and dorsal horn neurons (Sandkühler, 2009; Woolf and Salter, 2000). Late phase 
LTP lasts longer than 3h and requires protein synthesis. Long lasting 
modifications are caused by altered gene expression, loss of inhibitory 
interneurons and establishment of novel excitatory synaptic connections 
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(Sandkühler, 2009; Woolf and Salter, 2000). Signalling pathways in induction 
and maintenance of LTP involve activation of protein kinase C, mitogen-
activated protein kinase, protein kinase A, calcium/calmodulin-dependent protein 
kinase II, nitric oxide synthase, inositol triphosphate receptors, and ephrin-EphB2 
receptor tyrosine kinase (Ikeda et al., 2006; Ikeda et al., 2003; Song et al., 2008; 
Xin et al., 2006; Yang et al., 2004; Zhang et al., 2005). As reviewed above, LTP 
can be induced between primary afferent fibers and spinal dorsal horn neurons 
and may contribute to hyperalgesia caused by trauma, neuropathy, or 
inflammation (Sandkühler, 2007). 
 
The emerging literature implicates a role for glial cells and inflammatory 
cytokines in the genesis or maintenance of neuropathic and chronic pain (Watkins 
et al., 2007; Watkins and Maier, 2005). Under basal conditions, microglia and 
astrocytes do not appear to be important regulators of pain transmission in the 
nociceptive system. This conclusion is based on the fact that drugs that inhibit 
glial function do not influence responses to heat or mechanical stimuli in naive 
animals (Ledeboer et al., 2005; Meller et al., 1994).   
The role of glial cells in the spinal dorsal horn changes, following peripheral 
nerve injury (PNI) (Raghavendra et al., 2004; Tsuda et al., 2005; Watkins et al., 
2001; Zhuang et al., 2006). Upon peripheral nerve injury microglia and astrocytes 
become activated and undergo cell transition from bystander/surveillance states to 
enhanced response states. Enhanced response states include morphological and 
molecular changes in activated microglia and astrocytes (Tsuda et al., 2005; 
Zhuang et al., 2006). After stimulation, primary afferent fibers release 
neurotransmitters at their spinal terminals, which activate their cognate receptors 
on postsynaptic dorsal horn neurons and glial cells. Neurons and glial cells share 
the same types of ionotropic and metabotropic receptors which enable cross-talk 
between neurons and glia (Haydon, 2001; Watkins et al., 2008). Specific features 
of microglial and astrocytic responses are phosphorylation of mitogen activated-
protein kinase (MAPK) p38 and c-Jun N-terminal kinases (JNK) leading to the 
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production of multiple inflammatory mediators, such as cytokines IL-1ß, TNF-α, 
IL-6, chemokines, neurotrophic factors, proteases and prostaglandins. They 
modulate neuronal activity and contribute to nociceptive processing (Fig. 2) 
(DeLeo et al., 2004; Ji and Strichartz, 2004; Watkins et al., 2001; Watkins and 
Maier, 2003). 
 
                    
 
Figure 2: Activation of microglia and astrocytes following PNI. After PNI or tissue injury, 
primary afferent fibers release pain-related neurotransmitters, and activate ionotropic and 
metabotropic receptors on spinal dorsal horn neurons, microglia and astrocytes (1). Activation 
of these receptors induces cell transition from bystander/surveillance state to enhanced 
response state (2). Responses include morphological and molecular changes in microglia and 
astrocytes. Activation of microglia and astrocytes is associated with a hypertrophic, amoeboid 
shape and phosphorylation of MAPK p38 in microglia and JNK in astrocytes, leading to the 
production and release of various proinflammatory mediators (3). Glial-neuronal crosstalk 
modulates synaptic strength and contributes to nociceptive processing.  
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Astrocytes are the most abundant glial cell types within the central nervous 
system (CNS). Their processes form part of the blood brain barrier and they are 
also in close proximity to the synaptic cleft. Astrocytes communicate with each 
other via changes in [Ca
2+
]i. They respond to various neurotransmitters, such as 
glutamate with transient elevations of [Ca
2+
]i. Ca
2+
 is released  from intracellular 
stores after activation of metabotropic glutamate receptors (mGluRs) (Pasti et al., 
1997). The signal transduction pathway mediated by mGluRs activates 
phospholipase C which leads to the generation of inositol 1,4,5-trisphosphate 
(IP3) formed by hydrolysis of phosphatidylinositol 4,5 bisphosphate. IP3 is 
reported to trigger release of [Ca
2+
]i from  IP3-sensitive [Ca
2+
]i-stores (Berridge, 
1993) and subsequent release of gliotransmitters e.g. excitatory amino acids 
(EEA), ATP, cytokines, chemokines and prostaglandins (Volterra and Meldolesi, 
2005). Gliotransmitters can either act on receptors localized on glial cells 
themselves, or they can activate neuronal receptors. Increasing evidence suggests 
that gliotransmitters released by activated astrocytes can modulate neuronal 
excitability and synaptic transmission (Santello and Volterra, 2009). Cytokines 
like IL-1ß and TNF-α have been described as pain-related amplifiers in the 
nociceptive system (Milligan and Watkins, 2009; Watkins et al., 1995). TNF-α 
application is associated with an increasing surface expression of AMPA 
receptors and increase of EPSC-amplitudes (Beattie et al., 2002). Like TNF-α, 
IL-1ß, another proinflammatory cytokine expressed in glial cells, is thought to 
contribute to the induction of neuropathic and inflammatory pain. It facilitates 
perception of noxious stimuli at the spinal level by phosphorylation of the 
NMDA receptor subunit NR-1 (Zhang et al., 2008). Otherwise, application of IL-
1R antagonist alleviated inflammatory hyperalgesia and also prevented 
phosphorylation of NR-1 subunit in rats  (Zhang et al., 2008). Studies also 
showed that spinal LTP required activation of NMDA receptors (Ikeda et al., 
2003).  
 
 11 
Microglia are the resident macrophages of the brain and spinal cord and 
constitute 5 - 10% of the total glial cell population. Similar to astrocytes, 
microglia are also capable of releasing pro-inflammatory cytokines upon 
activation and changing their morphology, from a ramified into a hypertrophic, 
amoeboid shape (Clark et al., 2010; Tsuda et al., 2005). Studies showed that 
activation of microglia, induced surface-expression of P2X4 and phosphorylation 
of p38 MAPK, correlated with an increased pain-perception to noxious stimuli 
(hyperalgesia) and pain-perception to normally innocuous stimuli (allodynia) 
following peripheral nerve injury (PNI) (Tsuda et al., 2003; Tsuda et al., 2004). 
Recent findings suppose a specific role of microglia in the early-phase 
development of neuropathic pain. IL-1ß which is thought to be processed by 
different metalloproteases  (Kawasaki et al., 2008a), is reported to induce 
phosphorylation of p38 MAPK, thereby enhancing IL-1ß production, leading to 
increased pain sensitivity (Sung et al., 2005). These data suggested that cytokines 
mediate glial-neuronal crosstalk and that IL-1ß could have a crucial role in the 
modulation of synaptic transmission.  
The hypothesis was tested, whether glial cells contribute to the induction of spinal 
LTP (Fig. 3) and whether the proinflammatory cytokine IL-1ß can modulate 
synaptic tansmission.  
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Figure 3: Synaptic strength regulated by pre- and postsynapse, and glial release of 
proinflammatory mediators. Rise in [Ca
2+
]i in the postsynaptic cell induces LTP of synaptic 
strength. Mechanisms for synaptic plasticity in the spinal dorsal horn include phosphorylation 
of receptor/ion channels, receptor trafficking, induced gene expression, de novo protein 
synthesis and establishment of novel excitatory synaptic connections. 
  
We tested effects of IL-1ß on C-fiber evoked AMPAR and NMDAR mediated 
EPSCs respectively, and also on spontaneous EPSCs (sEPSCs). sEPSCs reflect 
the local global input of EPSCs following spontaneous release of all presynaptic 
terminals. Frequencies and amplitudes of sEPSCs were determined to study 
changes on receptor conductance and open probability.                          
LTP of C-fiber evoked EPSC amplitude was induced following HFS in lamina I 
neurons (Ikeda et al., 2003;Ikeda et al., 2006) (Fig. 5).  
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Figure 5: Induction of LTP following a conditioning stimulus. Here, LTP of C-fiber evoked 
EPSC amplitude (% of control) is plotted against time (min) and was induced following high-
frequency stimulation (HFS) between primary afferents and spinal lamina I neurons. Evoked 
EPSC amplitudes increased up to 500% (2), compared to pre-observations (dotted line) (1) (a) 
and were significantly potentiated for at least 30 minutes (n = 19), (p < 0.05) (b) (Gruber-
Schoffnegger, unpublished).  
 
Further unpublished results of our group have shown that astrocytes become 
activated upon HFS (Fig. 6) (Gruber-Schoffnegger, unpublished). 
 
                              
 
 
a 
b 
 14 
 
 
            
                                                   
 
Figure 6: Astrocytes respond to HFS with an [Ca
2+
]i-rise. Ca
2+
-imaging was performed in 
spinal cord slices labelled with the Ca
2+
-sensitive dye oregon green BAPTA 1-AM (OGB-1 
AM; green) (a) and the astrocyte specific marker sulfrhodamine 101 (red) (b). Marked neurons 
(arrows) and astrocytes (circles) are shown (a, b). Upon HFS, neurons  reacted with a [Ca
2+
]i-
rise and with a late, typical for astrocytes, delayed response, astrocytes  showed [Ca
2+
]i-
elevations (c) (Gruber-Schoffnegger, unpublished). 
 
c 
a 
b 
OGB-1 AM 
Sulforhodamine 101 
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Further results of our group have shown that in the presence of minocycline, a 
specific microglial inhibitor (Fig. 7a) and fluorocitrate, an inhibitor of 
astrocytytic and microglial citrate cycle (Fig. 7b) LTP was no longer inducible 
anymore by HFS. The data even revealed a long-term depression (LTD) of 
recorded C-fiber evoked EPSC amplitudes in fluorocitrate treated slices (Gruber-
Schoffnegger, unpublished).  
 
                                                                                   
    
 
Figure 7: Glial inhibition prevents induction of LTP by HFS in vitro. Here, C-fiber evoked 
EPSC amplitude (% of control) in lamina I neurons is plotted against time (min). In presence of 
minocycline HFS had no effects on the strength of synaptic transmission. C-fiber evoked EPSC 
amplitude stayed at control value (dotted line) following HFS (n = 9). (p > 0.05) (a). In 
presence of fluorocitrate, HFS induced LTD of C-fiber evoked EPSC amplitude (n = 9), (p <  
0.05) (b) (Gruber-Schoffnegger, unpublished). 
 
It has also been shown that, glial blockade by fluorocitrate and minocycline 
prevented induction of LTP by HFS in vivo (Fig. 8) (Gruber-Schoffnegger, 
unpublished). Recent findings also confirm assumptions of glial cells’ critical role 
in the induction of LTP (Henneberger et al., 2009).  
 
 
 
a b 
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Figure 8: Glial inhibition prevents induction of LTP by HFS in vivo. Area of C-fiber evoked 
field potential (% of control) recorded in lamina I of the spinal cord is plotted against time 
(min). LTP of C-fiber evoked field potential was induced following HFS (n = 7), (p < 0.05) (a). 
Systemic administration of fluorocitrate (n = 5) (b) and minocycline (n = 6) (c) 60 minutes 
prior to HFS prevented induction of LTP significantly (p < 0.05). (Gruber-Schoffnegger, 
unpublished).  
 
a 
b 
c 
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As reviewed above, IL-1ß has been shown to be released by activated glial cells 
(DeLeo et al., 2004; Ji and Strichartz, 2004; Watkins et al., 2001; Watkins and 
Maier, 2005). Furthermore IL-1ß has the potential to modulate the NMDA 
receptor (Zhang et al., 2008) which is of crucial importance for the induction of 
spinal LTP (Ikeda et al., 2006). Thus we tested the effects of IL-1ß on spinal 
lamina I neurons.  
First, our group has analyzed how many lamina I neurons expressed the IL-1R 
and could therefore directly react to the application of the cytokine. 
Immunohistochemical data showed that 67 ± 5% of lamina I neurons express the 
IL-1R (Fig. 9) (Guber-Schoffnegger, unpublished).  
       
 
 
Figure 9: Expression of IL-1R in spinal dorsal Lamina I neurons in naïve rats. 
Immunohistochemical staining revealed expression of IL-1R in 67 ± 5% of stained neurons. IL-
1R is shown in red (a), NeuN in green (b). Both pictures were merged to obtain overlapping 
expression (c) (Gruber-Schoffnegger, unpublished).  
 
Since most of the lamina I neurons could potentially react to application of IL-1ß, 
electrophysiological recordings in vitro and in vivo were performed to study its 
effects on C-fiber evoked EPSC amplitudes (Fig. 10) (Guber-Schoffnegger, 
unpublished).             
 18 
                                             
 
 
Figure 10: Effects of cytokine IL-1ß on the strength of synaptic transmission. IL-1ß increased 
the C-fiber evoked EPSC amplitude significantly compared to pre-observations (dotted line) in 
vitro (n = 8/15) (p < 0.05) (a ). IL-1ß had no effects on C-fiber evoked field potentials in vivo 
(n = 5) (p > 0.05) (b). C-fibre evoked EPSC amplitude/field potential are plotted against time 
(min) (Gruber-Schoffnegger, unpublished).  
 
Results of our group have shown that IL-1ß potentiated synaptic strength in 
spinal lamina I neurons in vitro. In vivo data revealed no effects of IL-1ß on 
magnitude of C-fiber evoked field potentials (Drdla, unpublished) (Fig. 10). We 
never tested if IL-1ß has differential effects on AMPAR- versus NMDAR- 
evoked EPSCs. Our group also tested whether IL-1ß thereby affected NMDAR 
and/or AMPAR mediated EPSCs between primary afferent fibers and spinal 
lamina I neurons. Results of our group revealed a considerable increase in C-fiber 
evoked NMDAR mediated EPSC amplitude after IL-1ß treatment (Fig. 11b) 
(Gruber-Schoffnegger, unpublished). These data suggest a crucial role of IL-1ß 
for the potentiation of C-fibre evoked NMDAR mediated EPSCs.  
 
a b 
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Figure 11: Effects of cytokine IL-1ß on NMDAR mediated currents. C-fiber evoked NMDAR 
mediated EPSC amplitude (% of control) is plotted against time (min) in control (n = 5) (a) and 
IL-1ß treated slices (n = 9) (b). IL-ß significantly potentiated C-fiber evoked NMDAR 
mediated EPSCs compared to pre-observations (dotted line) after application of IL-1ß (p < 
0.05) (Gruber-Schoffnegger, unpublished).   
 
The following data, including effects of IL-1ß on sEPSCs, AMPAR/NMDAR 
mediated currents, were collected within the framework of the diploma thesis to 
complete the research project. 
  
2. Materials & Methods 
 
2.1 Animals 
 
All procedures were in accordance with European Communities Council 
directives (86/609/EEC) and were approved by the Austrian Federal Ministry for 
Education, Science and Culture.  
 
 
a b 
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2.2 Preparation of spinal cord slices  
 
Spinal cord slices were obtained from young (18- to 23-day-old) Sprague-Dawley 
rats. Under deep ether anaesthesia rats were decapitated, the spinal cord was 
exposed by laminectomy and the lumbosacral segments with attached dorsal roots 
were excised. The dura mater and the ventral roots were removed. Transverse, 
500 μm thick spinal cord slices with a long (8-10 mm) dorsal root were cut on a 
microslicer (DTK-1000, Dosaka EM, Kyoto, Japan). Slices were incubated in a 
solution that consisted of (mM): NaCl: 95, KCl 1.8, KH2PO4 1.2, CaCl2 0.5, 
MgS04 7, NaHCO3 26, glucose 15, sucrose 50 and was oxygenated with 95% O2, 
5% CO2, pH 7.4. A single slice was then transferred to the recording chamber 
where it was superfused with oxygenated recording solution. Recordings were 
performed at 31°C. Recording solution was identical to the incubation solution 
except for (mM): NaCl 127, CaCl2 2.4, MgSO4 1.3, and sucrose 0. 
 
2.3 Recording and stimulation techniques 
 
Neurons were visualized with an Olympus BX 50/51WI (Olympus Optical, 
Tokyo, Japan) microscope equipped with Dodt-infrared optics (Dodt and 
Zieglgänsberger, 1990) and a video camera system. Standard whole-cell patch- 
clamp recording techniques were used. Patch pipette were made from borosilicate 
glass and filled with intracellular solution consisting of (mM): potassium 
gluconate 120, KCl 20, MgCl2 2, Na2ATP 2, Na-GTP 0.5, Hepes 20, EGTA 0.5, 
pH 7.28 with KOH and inserted into recording solution they had tip resistances of 
2-5 MΩ.  
Neurons in lamina I were selected for recording (Fig. 12a).  The 
electrophysiological properties of the recorded neurons were investigated in 
voltage-clamp modes using an Axopatch 700B amplifier. 
The dorsal root was stimulated with a suction electrode (Fig. 12b) with a constant 
current stimulator (World Precision Instruments, Stimulus Isolator, A360, 
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Sarasota, USA) and evoked excitatory postsynaptic currents (eEPSCs) were 
measured in the postsynaptic neuron.       
 
 
 
 
 
Figure 12: Transmission image of transverse slice with patch-clamped lamina I neuron (arrow) 
(a). Schematic of transverse slice with attached dorsal root stimulated via suction electrode (b). 
 
2.4 Experimental protocol 
 
The membrane potential was measured immediately after establishing the whole-
cell configuration. Only cells with a resting membrane potential more negative 
than –50 mV were investigated further. Membrane resistance, membrane time 
constant, membrane capacitance, series resistance and leak current were 
measured by means of a hyperpolarizing voltage step from –70 mV to –80 mV. 
a 
b dorsal root 
suction electrode 
patch pipette 
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Cells were usually excluded, if series resistance or holding current rose above 25 
MΩ and above 50 pA respectively. The background noise threshold for sEPSCs 
recordings was up to 2.7 pA. 
Afferent input was classified as C-fiber evoked, when calculated conduction 
velocity was below 2 m s
-1
. Monosynaptic input was identified by the absence of 
failures in response to 10 consecutive stimuli given at 2 Hz and a jitter below 
10% of response latencies. Conduction velocities of the responsible afferent 
fibers were calculated from the dorsal root length and the EPSC latency (Fig. 13). 
Synaptic delay of 1 ms was considered in calculation.  
LTP was induced by high-frequency stimulation (HFS) (3 x 100 Hz, 10 s 
intervall) of the ipsilateral dorsal roots. To measure excitatory postsynaptic 
potentials (EPSCs) from neurons in lamina I, test pulses of 0.1 ms were given at a 
30 s intervals. Effects of IL-1ß on evoked EPSC amplitudes were investigated. 
Therefore evoked EPSCs and evoked AMPAR mediated EPSCs were recorded at 
–70 mV, evoked NMDAR mediated EPSCs at –30 mV respectively. After three 
minutes baseline recording, IL-1ß was superfused for 20 minutes. Recordings 
then lasted for about 10 minutes for complete wash out of IL-1ß. In control 
experiments spinal cord slices were incubated with IL-1R antagonist for 10 
minutes and again superfused with IL-1ß for 10 minutes. Spontaneous EPSCs 
(sEPSCs) were recorded to investigate the local global input at a holding potential 
of –75 mV. We decided to set time point of IL-1ß wash-in 10 ½ min after start of 
recording. At this time-point sEPSC rate/amplitude of recorded control cells 
became more stable. IL-1ß was washed out 21 min after start of recording. 
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Figure 13: Example of C-fiber evoked monosynaptic responses in spinal lamina I neuron 
following electrical stimulation. Electrical stimulation induces C-fiber mediated EPSCs (pA) 
plotted against time (ms). Conduction velocity was calculated from the dorsal root length and 
sEPSC latency (delay). Different latencies of evoked EPSCs are called jitter.  
 
2.5 Data analysis 
 
The software pCLAMP 10.2 was used for data acquisitions and subsequent off-
line analysis. 
Additionally sEPSC frequencies and amplitudes were off-line analysed by use of 
MiniAnalysis software and visually checked afterwards. 
 
2.6 Statistics 
 
Data are presented as means ± SEM. Effects of IL-1ß on sEPSC frequency and 
amplitudes were analyzed using paired t-test/Student’s t-test for intra/inter-group 
comparisons. Effects of IL-1ß on evoked AMPAR EPSCs were analyzed with a 
one-way ANOVA. Comparison of control and IL-1ß treated groups in 
AMPAR/NMDAR experiments were analyzed with a Student’s t-test. A value of 
P < 0.05 was set as the level of statistical significance.  
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2.7 Application of drugs  
 
Spontaneous EPSCs were recorded in presence of bicuculline methiodide 
(bicuculline, 10 μM, Fluka) and strychnine (4 μM, Sigma), added to recording 
superfusion solution to block GABA A- and glycine- dependent receptors. 
Evoked AMPA-/ NMDA-EPSCs were also recorded in presence of bicuculline 
and strychnine. 
C-fiber evoked AMPAR EPSCs were blocked with CNQX (10 μM, Ascent) and 
C-fiber evoked NMDAR EPSCs were blocked with D-AP5 (50 μM, Ascent). 10 
μl IL-1ß (20 ng ml-1, rat recombinant, R&D Systems) was added to 10 ml 
perfusion solution in spontaneous EPSC and C-fibre evoked EPSCs. In negative 
contol experiments IL-1R antagonist (40 μg ml-1, human recombinant, AbD 
Serotec) was added. 
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3. Results 
 
3.1 Effects of IL-1ß on sEPSC rate and amplitude 
 
Recordings were obtained from 22 lamina I neurons. Eleven lamina I neurons 
were treated as controls, the other half was superfused with IL-1ß. There was a 
small but not significant decrease in rate (events s
-1
) and amplitude (pA) of IL-1ß 
treated cells compared to controls (p > 0.05) (Fig. 14).  
 
 
 
 
 
 
 
 
 
 
 
a b 
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Figure 14: Recordings of sEPSCs in spinal lamina I neurons. Increase/decrease of sEPSC 
rates/amplitudes in control (n = 11) and IL-1ß treated cells (n = 11) is shown (a). Examples of 
sEPSC recorded traces before and after wash in of IL-1ß compared to control (b). Rate and 
amplitude (% of control) of sEPSCs in control (black charts) and IL-1ß treated slices were 
measured (white charts). sEPSC rate: Control: 93.8 ± 11.6%  of  pre-wash in phase; Added IL-
1ß (20 ng ml
-1
): 80.7 ± 11.5% of pre-wash in phase (c); sEPSC amplitude: Control: 97.6 ± 
6.8% of  pre-wash in phase; Added IL-1ß: 91.3 ± 5.2% of pre-wash in phase (d); Treatment of 
spinal cord slices with IL-1ß neither significantly affected sEPSC rate nor sEPSC amplitude (P 
> 0.05 compared to control); Means ± SEM of rates and amplitudes were calculated and pre-
drug  phase was normalized to wash in phase of IL-1ß. 
 
 
c 
d 
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3.2 Effects of IL- 1ß on AMPAR currents 
 
Receptors important for primary afferent transmission are AMPA and NMDA 
receptors mainly. To check whether the major effect of IL-1ß is on AMPAR and 
/or the NMDAR component of the eEPSC, I measured AMPAR and NMDAR 
evoked EPSC amplitude separately. At first I obtained AMPAR mediated 
currents by application of bicuculline, strychnine and D-AP5 to selectively block 
NMDAR current. In eight cells, IL-1ß showed no wash in effect compared to 
control (n = 5) (p > 0.05) (Fig. 15b). Recordings of control cells which were not 
treated with IL-1ß did not show significant changes in synaptic transmission (p > 
0.05). These findings suggest that IL-1ß has no direct effects on the strength of 
synaptic transmission mediated by AMPA receptors.    
                            
 
Figure 15: Effects of cytokine IL-1ß on evoked AMPAR mediated currents. C-fiber evoked 
AMPA EPSC amplitude (% of control) is plotted against time (min) in control (n = 5) (A) and 
 
b 
a 
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IL-1ß superfused cells (n = 8) (B). IL-1ß had no significant effects on C-fiber mediated AMPA 
EPSCs (P > 0.05 compared to control; Kruskal-Wallis One Way Analysis of Variance on 
Ranks); Means ± SEM of amplitudes were calculated and plotted against time (min); 
Amplitudes of individual C-fiber evoked EPSCs were normalized to predrug values.  
 
3.3 Effects of IL-1ß on NMDAR currents 
 
The second important receptors involved in synaptic transmission between 
primary afferent and post-synaptic terminals are NMDARs. To test whether    IL-
1ß has any effects on NMDA mediated response, C-fiber evoked NMDAR EPSC 
amplitudes were measured (Fig. 11) (Gruber-Schoffnegger, unpublished). 
Application of IL-1ß seemed to be sufficient for longer lasting potentiation of 
NMDAR mediated EPSC amplitudes. To prove involvement of IL-1ß in 
potentiation of evoked NMDAR responses, I recorded C-fiber evoked NMDAR 
EPSCs in presence of IL-1R antagonist (40 μg ml-1). IL-1ß failed to potentiate C-
fiber mediated NMDAR currents in all recorded cells (n = 6) pretreated with IL-
1R antagonist compared to control (n = 6) (p > 0.05) (Fig. 16b). Recordings of 
control cells which were pre-treated with IL-1R antagonist did not show 
significant changes in synaptic transmission (p > 0.05) (Fig. 16a). 
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Figure 16: IL-1R antagonist inhibits IL-1ß mediated LTP of NMDAR mediated currents. C-
fiber evoked NMDAR EPSC amplitude (% of control) in control (n = 6) (a) and IL-1ß 
superfused cells (n = 6) (b). Slices were pretreated with IL-1R antagonist. IL-ß had no 
significant effects on C-fiber mediated NMDAR EPSCs (P > 0.05 compared to IL-1R 
antagonist control); Means ± SEM of amplitudes were calculated and plotted against time 
(min); Amplitudes of individual C-fiber evoked EPSCs were normalized to predrug values.  
 
 
 
 
 
a 
b 
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4. Discussion 
 
The present study supports hypothesis that IL-1ß, a proinflammatory cytokine 
importantly contributes to induction and maintenance of synaptic plasticity in the 
spinal dorsal horn. IL-1ß affected synaptic transmission, supporting our working 
hypothesis of glial dependent processes in synaptic plasticity.  
At first, members of our group induced LTP following HFS in spinal lamina I 
neurons. LTP lasted until the end of the recording period for at least 30 minutes, 
in 19 lamina I neurons tested (Fig. 5) (Gruber-Schoffnegger, unpublished). 
Earlier studies investigated a postsynaptic, Ca
2+
-dependent form of LTP induction 
in spinal lamina I neurons (Ikeda et al., 2003; Ikeda et al., 2006). Accumulating 
evidence indicates that glial cells contribute to the induction and maintenance of 
spinal LTP (Liu et al., 2007; Zhong et al., 2010). A Recent study showed, that 
sensory stimulation evokes astrocytic [Ca
2+
]i-rise within the barrel cortex of adult 
mice in vivo (Wang et al., 2006). Another study demonstrated an induced [Ca
2+
]i-
rise in spinal dorsal horn astrocytes by the purinergic receptor agonist BzATP and 
reported Ca
2+
-dependent forms of gliotransmission (Bardoni et al., 2010). 
Colleagues of our laboratory tested whether astrocytes showed a Ca
2+
-rise in 
response to HFS, the first approach to prove involvement of glial cells in spinal 
LTP. After increase of [Ca
2+
]i in neurons, also astrocytes reacted to stimulation of 
primary afferents with an increase in [Ca
2+
]i (Fig. 6) (Gruber-Schoffnegger, 
unpublished). Convincing evidence exists that [Ca
2+
]i variations can trigger 
release of Glutamate, ATP, D-Serine, cytokines like TNF-α and IL-1ß and 
prostaglandins (Santello and Volterra, 2009). In the next experiments my 
colleagues studied effects of glial inhibition, using minocycline or fluorocitrate, 
on the induction of LTP in vitro (Fig. 7) and in vivo (Fig.8) (Gruber-
Schoffnegger, unpublished). Minocycline is a specific inhibitor of microglial 
activation and sufficiently prevented the induction of LTP in vitro and in vivo 
(Fig.7a/8c). Other results may also indicate the crucial role of microglia in 
induction of spinal LTP (Zhong et al., 2010). Question arises whether astrocytes 
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are also necessary for the induction of LTP in spinal dorsal horn neurons. Recent 
studies on astrocytes suggest a role downstream to microglia (Tanga et al., 2004) 
and late involvement of astrocytic activation in the maintenance of increased 
nociception (Zhuang et al., 2005; Zhuang et al., 2006). Interestingly, data of my 
colleagues indicated a long-term depression (LTD) of C-fibre evoked EPSC 
amplitudes following HFS in flurocitrate treated slices (Fig. 7b). The mechanism 
of decrease in EPSC amplitudes has not been identified yet. One study showed 
that field EPSPs were markedly depressed after several hours of superfusion with 
flurocitrate, due to lack of glutamate, a product of the citric acid  cycle (Berg-
Johnsen et al., 1993). It has also been shown that fluorocitrate inhibited 
microglial activation after peripheral nerve injury (Clark et al., 2007). Studies 
indicate that activated microglia and astrocytes release various proinflammatory 
factors such as IL-1ß (Watkins et al., 2001; Watkins et al., 2007). The 
proinflammatory cytokine IL-1ß is of special interest as recent findings have 
already shown that IL-1ß facilitates perception of noxious inputs, mediating 
thermal and mechanical hyperalgesia (Reeve et al., 2000; Sung et al., 2004). To 
address question how many lamina I neurons could possibly be affected by 
release of IL-1ß, immunohistochemical studies were performed. Data of my 
colleagues revealed that more than half of spinal lamina I neurons expressed the 
IL-1R (Fig. 9) (Gruber-Schoffnegger, unpublished). In another set of experiments 
we tested the reaction of spinal lamina I neurons to application of IL-1ß. I first 
measured rate and amplitude of spontaneous EPSCs (sEPSCs) after treatment 
with IL-1ß in lamina I neurons (Fig. 14). Results showed a small, but not 
significant decrease in sEPSC frequency and amplitude. In literature, a decrease 
in sEPSC frequency is stated as a decrease in release probability of presynaptic 
vesicles whereas a decrease in sEPSC amplitude is rather associated with 
postsynaptic modifications. Findings suggest that global input onto lamina I 
neurons is not affected by IL-1ß. In parallel a recent study demonstrated a slight 
increase of sEPSC frequency and amplitude after IL-1ß treatment in 50% of 
spinal lamina II neurons (Kawasaki et al., 2008b). Further, IL-1ß reduced 
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spontaneous inhibitory postsynaptic currents (sIPSCs) indicating that IL-1ß 
controls both excitatory and inhibitory synaptic transmission (Kawasaki et al., 
2008b).  
Recordings in lamina I neurons revealed that IL-1ß significantly potentiated 
synaptic strength of C-fiber evoked EPSCs in vitro (Fig. 10a) however failed to 
induce potentiation C-fiber evoked field potentials in vivo (Fig. 10b) (Gruber-
Schoffnegger; Drdla, unpublished). To obtain further evidence in support of our 
results that IL-1ß could potentiate C-fibre evoked EPSCs in lamina I neurons, I 
tested effects of IL-1ß on AMPAR and NMDAR mediated currents. Application 
of IL-1ß did not significantly affect synaptic transmission of evoked AMPAR 
EPSCs compared to preobservations and control groups (Fig. 15). Withdrawal of 
IL-1ß showed also no effects on synaptic transmission. Interestingly, in contrast 
to AMPAR mediated currents, IL-1ß significantly potentiated C-fiber evoked 
NMDAR EPSCs (Fig. 11) (Gruber-Schoffnegger, unpublished). My colleagues 
still observed potentiation after wash out of IL-1ß, which suggests long lasting 
modifications of the NMDAR. These data are in parallel with other findings 
which reported potentiation of NMDA induced currents but not AMPA induced 
currents following application of IL-1ß (Kawasaki et al., 2008b). Results are also 
supported by the critical role of IL-1R signalling in modification of NMDAR 
subunit NR-1 (Zhang et al., 2008). In this study, a model of inflammatory 
hyperalgesia led to phosphorylation of the NR-1 subunit in superficial laminae of 
spinal dorsal horn. The authors applied an IL-1R antagonist which significantly 
inhibited phosphorylation of NR-1 and alleviated inflammatory hyperalgesia in 
rats (Zhang et al., 2008). Regarding these results I proved our hypothesis of 
cytokine induced LTP of C-fiber evoked NMDAR EPSCs by superfusion of IL-
1R antagonist. In none of the tested neurons IL-1ß did potentiate NMDAR 
mediated currents (Fig. 16). IL-1R antagonist had also no effects on basal 
synaptic transmission in control. In conclusion, the present study demonstrates 
that glial cells act as a synaptic amplifier of NMDAR mediated currents in 
nociceptive pathways of spinal lamina I neurons.  
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